Increased resistance to systemic Candidiasis in athymic or interleukin- 10-depleted mice

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 266-273

  Tavares, Delfina ^a,b   Ferreira, Paula ^a,b   Arala Chaves, Mário ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Institute Gulbenkian   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; PROTEIN P43; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRULENCE;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; BACTERIAL PROTEINS; CANDIDIASIS; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LIPOPROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; VIRULENCE FACTORS;

EID: 0033914467     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315674     Document Type: Article

References (51)

1. 1. Cutler JE, Lloyd RK. Enhanced antibody responses induced by Candida albicans in mice. Infect Immun 1982; 38:1102-8.
2. 2. Matthews RC, Burnie JP, Howat D, Rowland T, Walton F. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidiasis. Immunology 1991; 74:20-4.
3. 3. Polonelli L, Bernardis F, Conti S, et al. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies. J Immunol 1994; 152:3175-9.
4. 4. Han Y, Cutler JE. Antibody response that protects against disseminated candidiasis. Infect Immun 1995; 63:2714-9.
5. 5. Cassone A, Boccanera M, Adriani D, Santoni G, Bernardis F. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect Immun 1995; 63:2619-24.
6. 6. Elin RJ, Edelin JB, Wolff SM. Infection and immunoglobulin concentrations in Chediak-Higashi mice. Infect Immun 1974; 10:88-94.
7. 7. Hector RF, Domer JE, Carrow EW. Immune responses to Candida albicans in genetically distinct mice. Infect Immun 1982; 38:1020-8.
8. 8. Mahanty S, Greenfield RA, Joyce WA, Kincad PW. Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun 1988; 56:3162-6.
9. 9. Reitnauer PJ, Brown LR, Hank JA, Soudel PM. Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus transformed human lymphoblastoid B-cell lines. Cell Immunol 1986; 99:196-208.
10. 10. Tavares D, Ferreira P, Vilanova M, Videira A, Arala-Chaves M. Immunoprotection against systemic candidiasis in mice. Int Immunol 1995; 7: 785-96.
11. 1 lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect Immun 1989; 57:3581-7.
12. 12. Narayanan R, Joyce WA, Greenfield RA. Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect Immun 1991; 59:2116-9.
13. 13. Cutler JE. Acute systemic candidiasis in normal and congenially thymicdeficient (nude) mice. J Reticuloendothel Soc 1976; 19:121-4.
14. 1 lymphocytes in resistance to mucosal candidiasis. Infect Immun 1991; 59:2447-55.
15. 15. Ruthe RC, Andersen BR, Cunningham BL, Epstein RB. Efficacy of granulocyte transfusions in the control of systemic candidiasis in the leukopenic host. Blood 1978; 52:493-8.
16. 16. Tonnetti L, Spaccapelo R, Cenci E, et al. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol 1995; 25:1559-65.
17. 17. Capsoni F, Minonzo F, Ongari AM, Carbonelli V, Galli A, Zanussi C. Interleukin-10 down-regulates oxidative metabolism and antibody-dependent cellular cytotoxicity of human neutrophils. Scand J Immunol 1997;45: 269-75.
18. 18. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 178:2207-11.
19. 19. Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994; 152:3559-68.
20. 20. Tavares D, Salvador A, Ferreira P, Arala-Chaves M. Immunological activities of a Candida albicans protein which plays an important role in the survival of the microorganism in the host. Infect Immun 1993; 61:1881-8.
21. 21. Vilanova M, Tavares D, Ferreira P, Arala-Chaves M. Role of monocytes in up-regulation of early activation marker CD69 on B and T murine lymphocytes induced by microbial mitogens. Scand J Immunol 1996; 43: 155-63.
22. 22. Ferreira P, Soares R, Ribeiro A, Arala-Chaves MP. Correlation between specific immunosuppression and polyclonal B cell activation induced by a protein secreted by Streptococcus mutans. Scand J Immunol 1988; 27: 549-54.
23. 23. Ferreira P, Brás A, Tavares D, et al. Purification and biochemical and biological characterization of an immunosuppressive and lymphocyte mitogenic protein secreted by Streptococcus sobrinus. Int Immunol 1997; 9: 1735-43.
24. 24. Lima M, Bandeira A, Portnoi D, Ribeiro A, Arala-Chaves MP. Protective effect of a T cell dependent, immunosuppressive. B cell-mitogenic protein (F3'EP-Si or P90) produced by Streptococcus intermedius. Infect Immun 1992; 60:3571-8.
25. 25. Santarém MMG, Porto MT, Ferreira P, Soares R, Arala-Chaves M. Semipurification of an immunosuppressor substance secreted by Streptococcus mutans that plays a role in the protection of the bacteria in the host. Scand J Immunol 1987; 26:755-61.
26. 26. Soares R, Ferreira P, Santarém MMG, Teixeira da Silva M, Arala-Chaves M. Low T and B cell reactivity is an apparently paradoxical request for murine immunoprotection against Streptococcus mutans. Scand J Immunol 1990; 31:361-5.
27. 27. Arala-Chaves MP, Ribeiro A, Vilanova M, Porto MT, Santarém MMG, Lima M. Correlation between B cell mitogenicity and immunosuppressor effects of a protein released by porcine monocytes infected with African swine fever virus. Am J Vet Res 1988; 49:1955-61.
28. 28. Ribeiro A, Arala-Chaves MP, Vilanova M, Porto MT, Coutinho A. Role of B and T lymphocytes in the specific immunosuppression induced by a protein released by porcine monocytes infected with African swine fever virus. Int Immunol 1991; 3:165-74.
29. 29. Louria DB. Candida infections in experimental animals. In: Bodey GP, Fainstein V, eds. Candidiasis. New York: Raven Press, 1985:29-47.
30. 30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
31. 31. Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme linked immunospot-secreting cells. J Immunol Methods 1983; 65:109-12.
32. 32. Gronowicz E, Coutinho A, Melcher F. A plaque assay for all cells secreting 1g of a given type or class. Eur J Immunol 1976; 6:588-90.
33. 33. Forni L. Reagents for immunofluorescence and their use for studying lymphoid cell products. In: Lefkovitz I, Pernis B, eds. Immunological methods. New York: Academic Press, 1979:151.
34. 34. Bjorklund M, Coutinho A. Isotype commitment in the in vivo immune responses. II. Polyclonal plaque-forming cell responses to lipopolysaccharide in the spleen and bone marrow. Eur J Immunol 1983; 13:44-50.
35. 35. Appelberg R, Castro AG, Pedrosa J, Silva RA, Orme IM, Minoprio P. Role of gamma interferon and tumor necrosis factor alpha during T cell dependent and independent phases of Mycobacterium avium infection. 1994; 62:3962-71.
36. 36. Murray HW, Hariprashad J, Coffman RL. Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model. J Exp Med 1997; 185:867-74.
37. 37. Giger DK, Domer JE, Moser SA, McQuitty JT Jr. Experimental murine candidiasis: pathological and immune responses in T lymphocyte-depleted mice. Infect Immun 1978; 21:729-37.
38. 38. Rogers TJ, Balish E, Manning DD. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis. J Reticuloendothel Soc 1976; 20:291-8.
39. 39. Howard JG, Hale C, Liew FY. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J Exp Med 1980; 152:594-607.
40. 40. Minoprio P, Itohara S, Heusser C, Tonegawa S, Coutinho A. Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCR I T cells. Immunol Rev 1989; 112: 183-207.
41. 41. Vazquez-Torres A, Jones-Carson J, Wagner RD, Warner T, Balish E. Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect Immun 1999; 67:670-4.
42. 42. Linke A, Kuhn R, Muller W, Honarvare N, Li C, Langhome J. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol 1996; 84: 253-9.
43. + T cells and accompanied by over-production of IL-12, IFN-γ and TNF-α. J Immunol 1996; 157:798-805.
44. 44. Hunter CA, Ellis-Neyes LA, Slifer T, et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 1997; 158:3311-6.
45. 45. Fiorentino DF, Zlotnik A, Vieira P, et al. TL-10 acts on the antigen-presenting cells to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-51.
46. 46. O'Garra A, Stapleton G, Dhar V, et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990; 2:821-9.
47. 47. Onodera K, Volk HD, Ritter T, Kupiec-Weglinski JW. Thymus requirement and antigen dependency in the "infectious" tolerance pathway in transplant recipients. J Immunol 1998; 160:5765-72.
48. 48. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993; 259:974-7.
49. 49. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 1995; 3:171-4.
50. + T cells. Immunity 1994; 1:553-62.
51. 51. Bendelac A, Matzinger P, Seder RA, Paul WE, Shwartz RH. Activation events during thymic selection. J Exp Med 1992; 175:731-42.